Surgery Partners, Inc.: directors' dealings · United States · SEC (Form 4)

About Surgery Partners, Inc.

Surgery Partners, Inc. (NASDAQ: SGRY) is a U.S.-based healthcare services company focused on outpatient surgery and short-stay surgical care. Headquartered in Brentwood, Tennessee, in the United States, the company has built a physician-centric operating model designed to deliver efficient, cost-effective surgical care while maintaining clinical quality. Founded in 2004, Surgery Partners expanded through a mix of organic growth and acquisitions and has become one of the larger independent surgical services platforms in the U.S. market. ([ir.surgerypartners.com](https://ir.surgerypartners.com/news-releases/news-release-details/surgery-partners-inc-announces-fourth-quarter-and-full-year-2025?utm_source=openai)) Its asset base is diversified across ambulatory surgery centers (ASCs), surgical hospitals, multi-specialty physician practices, and urgent care facilities. This mix gives the company exposure to multiple points along the patient journey and supports a more integrated delivery model for physicians and patients. Surgery Partners also emphasizes ancillary services, including anesthesia and multi-specialty clinical support, which helps it broaden its service offering and participate in higher-acuity procedures where appropriate. ([ir.surgerypartners.com](https://ir.surgerypartners.com/news-releases/news-release-details/surgery-partners-inc-announces-fourth-quarter-and-full-year-2025?utm_source=openai)) From a competitive standpoint, Surgery Partners is positioned in a structurally attractive segment of U.S. healthcare. The ongoing shift of procedures from inpatient hospitals to lower-cost outpatient settings remains a key industry tailwind, and the company’s scale, national footprint, and specialization in short-stay surgery are central to its market position. Management indicates the company operates more than 250 locations across 30 states, giving it meaningful geographic reach while still remaining squarely focused on the United States. That footprint helps Surgery Partners compete with larger health systems and other independent ASC operators. ([ir.surgerypartners.com](https://ir.surgerypartners.com/investor-overview?utm_source=openai)) Recent developments have been notable. In the first quarter of 2026, Surgery Partners reported revenue growth of 4.5% and reaffirmed full-year 2026 guidance calling for at least $530 million of Adjusted EBITDA and revenue of $3.35 billion to $3.45 billion. In March 2026, the company also announced a share repurchase program. In addition, the stock has been a strategic focus: in January 2025, Surgery Partners confirmed receipt of a non-binding acquisition proposal from Bain Capital for the shares it did not already own. Together, these events highlight both the company’s operational momentum and the market’s strategic interest in its outpatient surgery platform. ([ir.surgerypartners.com](https://ir.surgerypartners.com/news-releases/news-release-details/surgery-partners-inc-announces-first-quarter-2026-results?utm_source=openai))